Suppr超能文献

膀胱癌患者的抑郁与焦虑:探究临床、人口统计学及社会心理预测因素

Depression and anxiety among patients treated for bladder cancer: examining clinical, demographic, and psychosocial predictors.

作者信息

Mohamed Nihal E, Leung Tung-Ming, Benn Emma Kt, Korn Talia G, Ali Imran, Patel Dhruti, Gonzalez Adam, Quale Diane Z

机构信息

Department of Urology and Oncological Science, Icahn School of Medicine at Mount Sinai New York, NY, USA.

Center for Biostatistics and Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai New York, NY, USA.

出版信息

Am J Clin Exp Urol. 2023 Oct 15;11(5):401-413. eCollection 2023.

Abstract

INTRODUCTION AND OBJECTIVE

The significant impact of bladder cancer and treatment on patient health related quality of life (HRQoL) and emotional wellbeing has been documented. Increasing evidence from cancer research emphasizes the importance of examining patients supportive care needs and received social support as factors that could influence their emotional adjustment. The purpose of the study was to assess the demographic and clinical predictors of depression and anxiety among bladder cancer patients and its associations with patient reported supportive care needs and perceived availability of social support.

METHODS

A cross-sectional design was used to investigate the study questions. Bladder cancer patients were recruited from the Bladder Cancer Advocacy Network (BCAN) to complete a questionnaire that included the Hospital Anxiety and Depression Scale (HADS), bladder cancer patient need survey (BCNAS-32), and the social provisions scale (SPS). The inclusion criteria restricted our sample to include bladder cancer patients who were English speakers, aged 18-85 years, and were able and willing to provide informed consent. Patients who had metastatic disease, cancer recurrence, or other primary cancers at the time of assessment were excluded from the study.

RESULTS

Participants included 159 bladder cancer patients. The mean age was 62±9.4 years and 51% were male. Almost two-thirds (62%) of patients reported a diagnosis of muscle invasive bladder cancer (MIBC), 25% patient reported clinically significant levels of anxiety, 17% reported clinically significant levels of depression, and 13% and 17% reported abnormal borderline abnormal levels for anxiety and depression, respectively. Univariate regression analyses revealed significant associations between HADS total score, HADS depression and anxiety subscales, patient age, physical functioning/daily living needs, sexuality needs, and perceived social support with higher total scores, anxiety, and depression scores associated with younger age, higher unmet needs, and lower levels of social support. Multivariate regression analyses, showed similar findings confirming the associations depicted by the univariate regression analyses.

CONCLUSIONS

Bladder cancer patients experience significant levels of depression and anxiety and these levels are associated with patient age, supportive care unmet needs and lack of social support. Patient focused interventions could be tailored to address these issues with the goal to improve patient HRQoL and emotional adjustment.

摘要

引言与目的

膀胱癌及其治疗对患者健康相关生活质量(HRQoL)和情绪健康有重大影响,这已得到证实。癌症研究中越来越多的证据强调,考察患者的支持性护理需求以及所获得的社会支持作为可能影响其情绪调适的因素的重要性。本研究的目的是评估膀胱癌患者中抑郁和焦虑的人口统计学及临床预测因素,及其与患者报告的支持性护理需求和感知到的社会支持可得性之间的关联。

方法

采用横断面设计来研究这些问题。从膀胱癌倡导网络(BCAN)招募膀胱癌患者,以完成一份问卷,其中包括医院焦虑抑郁量表(HADS)、膀胱癌患者需求调查(BCNAS - 32)和社会支持量表(SPS)。纳入标准将我们的样本限制为讲英语、年龄在18 - 85岁、能够且愿意提供知情同意的膀胱癌患者。评估时患有转移性疾病、癌症复发或其他原发性癌症的患者被排除在研究之外。

结果

参与者包括159名膀胱癌患者。平均年龄为62±9.4岁,51%为男性。近三分之二(62%)的患者报告诊断为肌层浸润性膀胱癌(MIBC),25%的患者报告临床上有显著水平的焦虑,17%的患者报告临床上有显著水平的抑郁,分别有13%和17%的患者报告焦虑和抑郁处于异常临界异常水平。单因素回归分析显示,HADS总分、HADS抑郁和焦虑子量表、患者年龄、身体功能/日常生活需求、性需求以及感知到的社会支持之间存在显著关联,总分、焦虑和抑郁得分较高与年龄较小、未满足需求较高以及社会支持水平较低相关。多因素回归分析显示了类似的结果,证实了单因素回归分析所描述的关联。

结论

膀胱癌患者经历显著水平的抑郁和焦虑,这些水平与患者年龄、支持性护理未满足需求以及缺乏社会支持有关。以患者为中心的干预措施可以针对性地解决这些问题,目标是改善患者的HRQoL和情绪调适。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验